DH (Definitive Healthcare) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DH Definitive Healthcare Corp DH
51 GF Score
Price $0.90
GF Value $4.07
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Definitive Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Definitive Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $11.4 Mil. Definitive Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $155.7 Mil. Definitive Healthcare's annualized EBITDA for the quarter that ended in Jun. 2026 was $34.4 Mil. Definitive Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 4.85.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Definitive Healthcare's Debt-to-EBITDA or its related term are showing as below:

DH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.22   Med: 5.04   Max: 11.73
Current: -0.97

During the past 7 years, the highest Debt-to-EBITDA Ratio of Definitive Healthcare was 11.73. The lowest was -1.22. And the median was 5.04.

DH's Debt-to-EBITDA is ranked worse than
100% of 482 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs DH: -0.97

Definitive Healthcare  (NAS:DH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Definitive Healthcare Debt-to-EBITDA Related Terms

Definitive Healthcare Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Definitive Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Definitive Healthcare Debt-to-EBITDA Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial - - - - -

Definitive Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DH vs HCAT, CCLD, OPRX: Debt-to-EBITDA Comparison

For the Health Information Services subindustry, Definitive Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Definitive Healthcare Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Debt-to-EBITDA falls into.


DH
51GF Score
Definitive Healthcare Corp DH
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Definitive Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Definitive Healthcare's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(11.429 + 161.237) / -141.858
=-1.22

Definitive Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(11.404 + 155.652) / 34.436
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Definitive Healthcare (DH) Overvalued in 2026?

Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued. The current stock price of $0.90 is trading 77.9% below its estimated GF Value™ of $4.07. GuruFocus considers Definitive Healthcare to be Possible Value Trap.

Key valuation signals for DH:

  • Debt-to-EBITDA:
  • GF Value™: $4.07 vs. price of $0.90 (77.9% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Definitive Healthcare Business Description

Address 492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score

Get the complete analysis for DH

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price
$4.07
GF Value